Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Epub 2012 Nov 29
We expect covid and foreign-exchange headwinds to subside for the remainder of the year, allowing Roches underlying growth to become more apparent to investors
Moving forward, the results of the phase 3 SURPASS clinical trial program demonstrated that tirzepatide was as effective and safe as other anti-diabetic agents, such as semaglutide and dulaglutide (SURPASS-2) (SURPASS J-mono), long-acting insulin analogs (degludec and glargine) (SURPASS-3,4), and placebo (SURPASS-1) (SURPASS-5), in managing T2DM diabetes [65,66,67,68,69]
Semaglutide is available as both tablets and injections, while tirzepatide is only available as an injection
US$ 21.74
US$ 25.05
US$ 22.90
US$ 23.76
US$ 28.64
US$ 20.37
US$ 24.24
